Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

CJC-1295 (No DAC) Handling Guide: Common Mistakes to Avoid

Most handling advice for research peptides is written generically. The practices below are the ones that specifically matter for CJC-1295 (No DAC) — including the mistakes it is unusually easy to make with this compound.

GHRH(1-29) tetra-substituted analogue (DAC-free)Hormonal & EndocrineMetabolic

Overview

Room temperature before opening, swirl do not shake, aliquot and refrigerate — never re-freeze the solution.

What CJC-1295 (No DAC) actually is

A trimmed, stabilised piece of the natural growth-hormone-releasing hormone that nudges the pituitary to release GH in short, natural pulses. Leaving off the DAC part keeps it short-acting, which is what researchers study it for. Often searched as Modified GRF 1-29.

Supplied for laboratory research use only — not for human or animal use.

Research-grade CJC-1295 (No DAC)

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Bench practices for CJC-1295 (No DAC)

  • Reach room temperature before opening.
  • Swirl to dissolve; do not shake or vortex — foam indicates interfacial stress on the helix.
  • Aliquot and refrigerate; never re-freeze reconstituted solution.

The chemistry behind these practices

  • Deamidation at Asn/Gln residues over long solution storage.
  • Interfacial aggregation of the amphipathic helix if foamed.
  • Microbial growth in non-preserved diluent.

Storage summary

LyophilizedSealed powder stable at -20 °C.
ReconstitutedRefrigerate at 2-8 °C; do not freeze once reconstituted.

What CJC-1295 (No DAC) is studied for

Pulsatile GH release

Studied for prompting growth-hormone release in short, physiological pulses via the GHRH receptor.

DPP-4 resistance

The four substitutions are studied for extending the molecule beyond the minutes-long survival of native GHRH.

Complementary pairing

Frequently studied alongside ghrelin-receptor secretagogues such as Ipamorelin, which recruit a second GH-release pathway.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More CJC-1295 (No DAC) reference

Lab Handling reference for other compounds

CJC-1295 (No DAC) overview CJC-1295 (No DAC) calculatorCJC-1295 (No DAC) product details

CJC-1295 (No DAC) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.